Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04393558 · ClinicalTrials.gov registry record
Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms
A clinical trial, sponsored by Shirley Ryan AbilityLab.
- Completed
- Registry status
- 75
- Enrollment target
NCT04393558 is a clinical trial that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 75 participants.
The verdict
NCT04393558 has completed, sponsored by Shirley Ryan AbilityLab.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
1. Develop a wearable sensor package to gather data on COVID-19-like signs and symptoms such as elevated body temperature, respiratory parameters, heart rate ,cough and gait. 2. Create algorithms to monitor and track changes to COVID19-like signs and symptoms for developing a better care and isolation strategies for COVID-19 pandemic.
Interventions
- DEVICE ADAM Sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2020-04-20 |
| Est. Completion | 2020-10-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04393558
The ClinicalTrials.gov registry entry for NCT04393558 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ADAM Sensor is the first listed.
NCT04393558 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04393558 about?
NCT04393558 is a clinical study titled "Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms". 1. Develop a wearable sensor package to gather data on COVID-19-like signs and symptoms such as elevated body temperature, respiratory parameters, heart rate ,cough and gait. 2. Create algorithms to monitor and track changes to COVID19-like signs and symptoms for developing a better care and isolati...
What is the current status of trial NCT04393558?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2020-04-20. Estimated completion is 2020-10-26.
What interventions are being tested in trial NCT04393558?
The interventions under investigation include: ADAM Sensor (DEVICE).
Who is sponsoring clinical trial NCT04393558?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.